Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Crescent Capital BDC (FCRX) Other Non Operating Income (2021 - 2025)

Historic Other Non Operating Income for Crescent Capital BDC (FCRX) over the last 5 years, with Q3 2025 value amounting to -$105000.0.

  • Crescent Capital BDC's Other Non Operating Income fell 27796.61% to -$105000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$915000.0, marking a year-over-year increase of 4991.79%. This contributed to the annual value of -$1.2 million for FY2024, which is 1839.72% up from last year.
  • As of Q3 2025, Crescent Capital BDC's Other Non Operating Income stood at -$105000.0, which was down 27796.61% from -$456000.0 recorded in Q2 2025.
  • Crescent Capital BDC's Other Non Operating Income's 5-year high stood at $357000.0 during Q1 2025, with a 5-year trough of -$5.6 million in Q1 2023.
  • For the 5-year period, Crescent Capital BDC's Other Non Operating Income averaged around -$528588.2, with its median value being -$73000.0 (2022).
  • In the last 5 years, Crescent Capital BDC's Other Non Operating Income crashed by 496296.3% in 2023 and then skyrocketed by 334545.45% in 2025.
  • Crescent Capital BDC's Other Non Operating Income (Quarter) stood at -$670000.0 in 2021, then surged by 95.97% to -$27000.0 in 2022, then tumbled by 4962.96% to -$1.4 million in 2023, then skyrocketed by 47.99% to -$711000.0 in 2024, then soared by 85.23% to -$105000.0 in 2025.
  • Its last three reported values are -$105000.0 in Q3 2025, -$456000.0 for Q2 2025, and $357000.0 during Q1 2025.